Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 20 to 35 Women only

Using Misoprostol to Prevent Respiratory Issues in Newborns During Elective Cesarean Sections

Official title: Misoprostol Administration Before Elective Caesarean Section to Reduce the Risk of Respiratory Morbidity in Newborns

Run by Kafrelsheikh University · NCT06946914 · Data updated 2026-11-12

This study is testing if giving Misoprostol to pregnant women before planned cesarean sections can help reduce breathing problems in their newborns.

Quick facts

PhasePhase 4
Study typeInterventional
Ages20 Years to 35 Years
SexWomen only
Enrollment160 (estimated)
SponsorKafrelsheikh University
Academic / other
Locations1 site (Kafr Ash Shaykh, Egypt)
StatusRecruiting
StartedJune 1, 2024
Main results expectedJune 1, 2025
Study endsAugust 1, 2025
Registry record updatedMay 13, 2025
Trial IDNCT06946914 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women under 35 years old, with singleton pregnancies, and scheduled for elective cesarean sections before 38 weeks of gestation.

Probably not a fit

Patients with obstetric disorders, contraindications to Misoprostol, or a history of multiple cesarean sections may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of administering Misoprostol before elective cesarean sections in pregnant women under 38 weeks gestation to reduce neonatal respiratory morbidity. Given the high incidence of respiratory distress syndrome in newborns delivered via cesarean, the research aims to determine if Misoprostol can mitigate these risks. The study will include women with singleton pregnancies and no major anomalies, while excluding those with certain obstetric disorders or contraindications to Misoprostol. The findings could provide valuable insights into improving neonatal outcomes in cesarean deliveries.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the incidence of respiratory distress syndrome in newborns delivered by elective cesarean section.

How similar studies have gone: While the use of Misoprostol in obstetric settings is established, this specific application for preventing neonatal respiratory issues during elective cesarean sections is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women with indication for elective caesarean section.
* Age less than 35 years old.
* Gestational age less than 38 weeks.
* Gestational age will be confirmed by certain LMP or reliable early ultrasound measurement of crown-rump length.
* Singleton pregnancy with no major anomalies

Exclusion Criteria:

* Any obstetric disorders as preeclampsia and diabetes.
* Fetus with oligohydramnios, intrauterine growth restriction.
* Any contraindications to misoprostol like those with previous allergic reaction or hypersensitivity to prostaglandin hemorrhagic disorders, and severe anemia.
* History of more than or equal 2 previous caesarean section.

Where it's running

  • Kafr El-sheikh University Hospital
    Kafr Ash Shaykh, Egypt, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.